Clinical Report of 46 Intracranial Tumors with LINAC Based Stereotactic Radiosurgery.
- Author:
Sei C YOON
1
;
Tae S SUH
;
Sung W KIM
;
Ki M KANG
;
Yun S KIM
;
Byung O CHOI
;
Hong S JANG
;
Kyo H CHOI
;
Moon C KIM
;
Kyung S SHINN
Author Information
1. Department of Radiology, Kangnam St. Mary's Hospital, Catholic University Medical College, Seoul, Korea.
- Publication Type:Original Article
- Keywords:
Stereotactic radiosurgery;
Linac based;
Pituitary tumor;
Acoustic neurinoma;
Meningioma;
Glioma;
Craniopharyngioma;
Pinealoma;
Hemangioblastoma;
Metastatic brain tumor
- MeSH:
Acoustics;
Analgesics;
Brain;
Craniopharyngioma;
Female;
Follow-Up Studies;
Glioma;
Hair;
Headache;
Hemangioblastoma;
Humans;
Lung Neoplasms;
Magnetic Resonance Imaging;
Male;
Meningioma;
Neuroma, Acoustic;
Pinealoma;
Pituitary Neoplasms;
Radiation Oncology;
Radiosurgery*
- From:Journal of the Korean Society for Therapeutic Radiology
1993;11(2):241-248
- CountryRepublic of Korea
- Language:English
-
Abstract:
Between July 1988 and December 1992, we treated 45 patients who had deep seated inoperable or residual and/or recurrent intracranial tumors using LINAC based stereotactic radiosurgery at the Department of Therapeutic Radiology, Kangnam St. Mary's Hospital, Catholic University Medical College. Treated intracranial tumors included pituitary tumors(n=15), acoustic neurinomas(n=8), meningiomas(n=7), gliomas(n=6), craniopharyngiomas(n=4), pinealomas(n=3), hemangioblastomas(n=2), and solitary metastatic tumor from lung cancer (n=1). The dimension of treatment field varied from 0.23 to 42.88 cm3(mean ; 7.26 cm3). The maximum tumor doses ranging from 5 to 35.5 Gy (mean; 29.9 Gy) were given, and depended on patients' age, target volume, location of lesion and previous history of irradiation. There were 22 male and 23 female patients. The age was varied from 5 to 74 years of age(a median age; 43 years). The mean duration of follow-up was 35 months (2~55 months). To date, 18(35.1%) of 46 intracranial tumors treated with SRS showed absent or decrease of the tumor by serial follow-up CT and/or MRI and 16(34.8%) were stationary, e.g. growth arrest. From the view point of the clinical aspects, 34(73.9%) of 46 tumors were considered improved status, that is, alive with no evidence of active tumor and 8(17.4%) of them were stable, alive with disease but no deterioration as compared with before SRS. Although there showed slight increase of the tumor in size according to follow-up imagings of 4 cases(pituitary tumor 1, acoustic neurinomas 2, pinealoma 1), they still represented clinically stable status. Clinically, two(4.4%) patients who were anaplastic astrocytoma(n=1) and metastatic brain tumor(n=1) were worsened following SRS treatment. So far, no serious complications were found after treatment. The minor degree headache which could be relieved by steroid or analgesics and transient focal hair loss were observed in a few cases. There should be meticulous long term follow-up in all cases.
